Journals / Haydarpaşa Numune Medical Journal / 2019 / Cilt: 59 - Sayı: 2

Evaluating Corneal Changes in Patients with Aortic Aneurysm

Pages
136–141
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Discussion and Conclusion: The patients diagnosed with aortic aneurysm should be evaluated for keratoconus.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: To evaluate corneal changes in patients with aortic aneurysm.
📊
Key Findings & Data:Methods: The study group (Group 1) included 63 eyes of 33 patients diagnosed with aortic aneurysm and the control group (Group 2) included 69 eyes of 35 healthy people who presented at the Ophthalmology Department.
💡
Conclusion & Impact:Discussion and Conclusion: The patients diagnosed with aortic aneurysm should be evaluated for keratoconus.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Introduction: To evaluate corneal changes in patients with aortic aneurysm. Methods: The study group (Group 1) included 63 eyes of 33 patients diagnosed with aortic aneurysm and the control group (Group 2) included 69 eyes of 35 healthy people who presented at the Ophthalmology Department. Complete ophthalmologic examination was performed and steepest keratometry measurements were taken via rotational Scheimpflug corneal tomography on the following parameters: sagittal curvature map (S steepest), central corneal thickness (CCT), minimum corneal thickness (CT min), corneal volume (CV), mean pachymetric progression index (PPI mean), minimum PPI (PPI min), maximum PPI (PPI max), maximum Ambrosio relational thickness (ART max), posterior corneal elevation (PE) and back difference elevation (BDE). Results: The groups were similar in terms of age and gender (p=0.082 and p=0.145, respectively). There was no statistically significant difference in visual acuity and intraocular pressure between the groups (p=0.471 and p=0.199 respectively). There was no statistically significant difference in Ks, Kf, Km, CT min, CCT, CV, I-S, S steepest, PE, PPI mean, PPI min, PP max, and ART max values between the groups (p>0.05). BDE value was significantly higher in Group 1 (p=0.04). Discussion and Conclusion: The patients diagnosed with aortic aneurysm should be evaluated for keratoconus.

🔖

Cite This Article

AKINCI, B., AYAR, O., KALAYCI, B., UĞURBAŞ, S. H. (2019). Evaluating Corneal Changes in Patients with Aortic Aneurysm. Haydarpaşa Numune Medical Journal, Cilt: 59 - Sayı: 2, 136–141. https://ajindex.com/articles/190429

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Rabinowitz YS. Keratoconus. Surv Ophthalmol 1998
  2. 297– 319. [CrossRef ] 2. Sugar J, Macsai MS. What causes keratoconus? Cornea 2012
  3. 716–9. [CrossRef ] 3. Rabinowitz YS. The genetics of keratoconus. Ophthalmol Clin North Am 2003
  4. 607–20. [CrossRef ] 4. Pescosolido N, Barbato A, Pascarella A, Giannotti R, Genzano M, Nebbioso M. Role of Protease-Inhibitors in Ocular Diseases. Molecules 2014
  5. 20557–69. [CrossRef ] 5. Sawaguchi S, Twining SS, Yue BY, Chang SH, Zhou X, Loushin G, et al. Alpha 2-macroglobulin levels in normal human and keratoconus corneas. Invest Ophthalmol Vis Sci 1994
  6. 4008–14. 6. Mootha VV, Kanoff JM, Shankardas J, Dimitrijevich S. Marked reduction of alcohol dehydrogenase in keratoconus corneal fibroblasts. Mol Vis 2009
  7. 706–12. 7. Kenney MC, Chwa M, Atilano SR, Tran A, Carballo M, Saghizadeh M, et al. Increased levels of catalase and cathepsin V/L2 but decreased TIMP-1 in keratoconus corneas: evidence that oxidative stress plays a role in this disorder. Invest Ophthalmol Vis Sci 2005
  8. 823–32. [CrossRef ] 8. Dudakova L, Liskova P, Trojek T, Palos M, Kalasova S, Jirsova K. Changes in lysyl oxidase (LOX) distribution and its decreased activity in keratoconus corneas. Exp Eye Res 2012
  9. 74–81. 9. Beardsley TL, Foulks GN. An association of keratoconus and mitral valve prolapse. Ophthalmology 1982
  10. 35–7. [CrossRef ] 10. Lichter H, Loya N, Sagie A, Cohen N, Muzmacher L, Yassur Y, et al. Keratoconus and mitral valve prolapse. Am J Ophthalmol 2000
  11. 667–8. [CrossRef ] 11. Kalkan Akcay E, Akcay M, Uysal BS, Kosekahya P, Aslan AN, Caglayan M, et al. Impaired corneal biomechanical properties and the prevalence of keratoconus in mitral valve prolapse. J Ophthalmol 2014
  12. 402193. [CrossRef ] 12. Ozer PA, Yalniz-Akkaya Z. Congenital keratoglobus with multiple cardiac anomalies: a case presentation and literature review. Semin Ophthalmol 2015
  13. 305–12. [CrossRef ] 13. Dudakova L, Jirsova K. The impairment of lysyl oxidase in keratoconus and in keratoconus-associated disorders. J Neural Transm (Vienna) 2013
  14. 977–82. [CrossRef ] 14. Gomes JA, Tan D, Rapuano CJ, Belin MW, Ambrósio R Jr, Guell JL, et al. Global consensus on keratoconus and ectatic diseases. Cornea 2015
  15. 359–69. [CrossRef ] 15. Pinsard L, Touboul D, Vu Y, Lacombe D, Leger F, Colin J. Keratoconus associated with Williams-Beuren syndrome: first case reports. Ophthalmic Genet 2010
  16. 252–6. [CrossRef ] 16. Greenfield G, Stein R, Romano A, Goodman RM. Blue sclerae an